跳至主要内容
临床试验/PACTR202305650866475
PACTR202305650866475尚未招募1 期

Assessing the therapeutic effect of probiotics on individuals with mild cognitive impairment at Korle - Bu Teaching Hospital.

WESTERN SYDNEY UNIVERSITY0 个研究点目标入组 120 人开始时间: 2023年5月11日最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65 Year(s) 至 150 Year(s)(—)
性别
All

入选标准

  • The subject is between 50-75 years old.
  • The subject is clinically diagnosed with Mild cognitive impairment by the Neurologist.
  • The subject's MoCA score is between 10-26.
  • The subject can cooperate to perform cognitive function tests.
  • The subject has dependable caregivers who can record the compliance of taking probiotics and any physical conditions.
  • The subject or family members signed the informed consent form and answered the questionnaire.

排除标准

  • The subject has dementia caused by other reasons, such as brain trauma, tumour, infection, epilepsy, etc.
  • The subject has consumed probiotic-related products (probiotic powder, yoghurt or other fermented foods) within the past 1 month.
  • The subject has participated in clinical trials of other dementia medications in the past 1 month.
  • The subject is assessed for dementia caused by vitamin B12 deficiency or thyroid abnormalities.
  • The subject suffers from mental illness, severe depression, schizophrenia, drug addiction, and alcohol addiction.
  • The subject has Parkinson's disease.
  • The subject is assessed to have severe metabolic and liver and kidney dysfunction.

研究者

相似试验